Illumina (ILMN) and the Center for Data-Driven Discovery in Biomedicine said Tuesday they have launched a data partnership to advance research in pediatric cancer and rare diseases.
Under the initiative, D3b will analyze 100,000 whole genomes from pediatric patients using Illumina software to build a unified genomic dataset.
The data will be made available through the Gabriella Miller Kids First Data Resource Center to support research and clinical insights, the companies said.
The dataset will include genomes from patients with rare congenital conditions and cancers collected through federally funded programs, including the Children's Brain Tumor Network.
Illumina is also joining the Pediatric Care eXpansion program of the Advanced Research Projects Agency for Health, aimed at accelerating diagnosis and treatment by expanding data-sharing across more than 200 pediatric institutions in the US, according to a joint statement.
Price: $129.43, Change: $+2.47, Percent Change: +1.95%